Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2021-08-04 00:00:00 ET · period of report 2021-08-02 · accession 0001209191-21-049602 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-08-04 | 2021-08-02 | VRTX | SACHS BRUCE I | Dir | P - Purchase | $197.91 | +15.0K | 41.2K | +57% | +$2.97M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-02 | P | A | 15,000 | $197.91 | 41,210 | D | — | — | (F2) Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares purchased at each separate price. (F1) Open market sales reported on this line occurred at a weighted average price of $197.91 (range $197.45 to $198.12). |